PRO-DEX, INC. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-03: Form 10-K; Period of report 2026-06-30; Description ANNUAL REPORT; Document pdex_10k-063026.htm.
- 2025-09-04: Form 10-K; Period of report 2025-06-30; Description ANNUAL REPORT; Document pdex_10k-063025.htm.
- 2024-09-05: Form 10-K; Period of report 2024-06-30; Description ANNUAL REPORT; Document pdex_10k-063024.htm.
- 2023-10-13: Form 10-K; Period of report 2023-06-30; Description ANNUAL REPORT; Document pdex_10k-063023.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-03 | 10-K | 2026-06-30 | ANNUAL REPORT | pdex_10k-063026.htm |
| 2025-09-04 | 10-K | 2025-06-30 | ANNUAL REPORT | pdex_10k-063025.htm |
| 2024-09-05 | 10-K | 2024-06-30 | ANNUAL REPORT | pdex_10k-063024.htm |
| 2023-10-13 | 10-K | 2023-06-30 | ANNUAL REPORT | pdex_10k-063023.htm |
| 2022-09-08 | 10-K | 2022-06-30 | ANNUAL REPORT | pdex_10k.htm |
| 2021-09-09 | 10-K | 2021-06-30 | ANNUAL REPORT | pdex_10k.htm |
| 2020-09-10 | 10-K | 2020-06-30 | ANNUAL REPORT | pdex_10k.htm |
| 2019-09-12 | 10-K | 2019-06-30 | ANNUAL REPORT | pdex_10k.htm |
| 2018-09-13 | 10-K | 2018-06-30 | ANNUAL REPORT | pdex_10k.htm |
| 2017-09-14 | 10-K | 2017-06-30 | ANNUAL REPORT | pdex_10k.htm |
| 2016-09-15 | 10-K | 2016-06-30 | 10-K FILING | f16-0825.htm |
| 2015-09-17 | 10-K | 2015-06-30 | 10-K FILING | f15-0668.htm |
| 2014-09-18 | 10-K | 2014-06-30 | 10-K | f14-0686.htm |
| 2013-09-27 | 10-K | 2013-06-30 | FORM 10-K | rhf130711_10-k.htm |
| 2012-09-12 | 10-K | 2012-06-30 | FORM 10-K | d357283d10k.htm |
| 2011-09-14 | 10-K | 2011-06-30 | FORM 10-K | d229987d10k.htm |
| 2010-09-28 | 10-K | 2010-06-30 | Annual report | espdex10k.htm |
| 2009-09-17 | 10-K | 2009-06-30 | Annual report | espdex10k.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |